Roberto Freilone
-
- Lymphoma Diagnosis and Treatment 30
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 15
- Myeloproliferative Neoplasms: Diagnosis and Treatment 5
- Virus-based gene therapy research 3
- Oncology top 10%
- CAR-T cell therapy research 9
- Viral-associated cancers and disorders 7
- Neurology top 10%
- CNS Lymphoma Diagnosis and Treatment 10
- Hematology top 10%
- Acute Myeloid Leukemia Research 8
- Co-authors
- Barbara BottoUmberto VitoloM BertiniLorella OrsucciL ResegottiAlessandro LevisGianluca GaïdanoDomenico Novero
- Partner nations
- ItalyGermanyUnited States
In The Last Decade
Roberto Freilone
43 papers receiving 586 citations
Peers
Comparison fields: 5 of 46
- Pathology and Forensic Medicine 420
- Genetics 230
- Oncology 321
- Neurology 151
- Hematology 94
Countries citing papers authored by Roberto Freilone
This map shows the geographic impact of Roberto Freilone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Freilone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Freilone more than expected).
Fields of papers citing papers by Roberto Freilone
This network shows the impact of papers produced by Roberto Freilone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Freilone. The network helps show where Roberto Freilone may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Roberto Freilone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 6 | |
| 8 | 2023 | 7 | |
| 9 | 2023 | 16 | |
| 10 | 2023 | 5 | |
| 11 | 2022 | 29 | |
| 12 | 2022 | 5 | |
| 13 | 2018 | 3 | |
| 14 | 2016 | 16 | |
| 15 | R-CVP versus R-CHOP versus R-FM as first-line therapy for advanced-stage follicular lymphoma: Final results of FOLL05 trial from the Fondazione Italiana Linfomi (FIL) | 2012 | 6 |
| 16 | 2009 | 1 | |
| 17 | 1998 | 79 | |
| 18 | 1997 | 52 | |
| 19 | 1996 | 32 | |
| 20 | 1996 | 50 |
About Roberto Freilone
Roberto Freilone is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology, having authored 46 papers that have together received 591 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (30 papers), Chronic Lymphocytic Leukemia Research (15 papers), CNS Lymphoma Diagnosis and Treatment (10 papers), CAR-T cell therapy research (9 papers), Acute Myeloid Leukemia Research (8 papers), Viral-associated cancers and disorders (7 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Virus-based gene therapy research (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (420 citations), Genetics (230 citations) and Oncology (321 citations). Roberto Freilone has collaborated with scholars based in Italy, Germany and United States. Frequent co-authors include Barbara Botto, Umberto Vitolo, M Bertini, Lorella Orsucci, L Resegotti, Alessandro Levis, Gianluca Gaïdano, Domenico Novero, Ernesta Audisio and Giorgio Palestro. Their work appears in journals such as Blood, Cancers, Annals of Oncology, Annals of Hematology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.